LITHIUM CARBONATE ER tablet Spojené štáty - angličtina - NLM (National Library of Medicine)

lithium carbonate er tablet

remedyrepack inc. - lithium carbonate (unii: 2bmd2gna4v) (lithium cation - unii:8h8z5uer66) - lithium carbonate 450 mg

LITHIUM CARBONATE tablet extended release Spojené štáty - angličtina - NLM (National Library of Medicine)

lithium carbonate tablet extended release

avera mckennan hospital - lithium carbonate (unii: 2bmd2gna4v) (lithium cation - unii:8h8z5uer66) - lithium carbonate 450 mg

Lloydspharmacy Heartburn and Indigestion liquid peppermint Spojené kráľovstvo - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

lloydspharmacy heartburn and indigestion liquid peppermint

lloyds pharmacy ltd - sodium alginate; calcium carbonate; sodium bicarbonate - oral suspension - 50mg/1ml ; 16mg/1ml ; 26.7mg/1ml

LITHIUM CARBONATE tablet, extended release Spojené štáty - angličtina - NLM (National Library of Medicine)

lithium carbonate tablet, extended release

carilion materials management - lithium carbonate (unii: 2bmd2gna4v) (lithium cation - unii:8h8z5uer66) - lithium carbonate is indicated in the treatment of manic episodes of manic-depressive illness. maintenance therapy prevents or diminishes the intensity of subsequent episodes in those manic-depressive patients with a history of mania. typical symptoms of mania include pressure of speech, motor hyperactivity, reduced need for sleep, flight of ideas, grandiosity, elation, poor judgment, aggressiveness and possibly hostility. when given to a patient experiencing a manic episode, lithium carbonate may produce a normalization of symptomatology within 1 to 3 weeks.

LITHIUM CARBONATE ER- lithium carbonate tablet Spojené štáty - angličtina - NLM (National Library of Medicine)

lithium carbonate er- lithium carbonate tablet

bryant ranch prepack - lithium carbonate (unii: 2bmd2gna4v) (lithium cation - unii:8h8z5uer66) - lithium carbonate extended-release tablets are indicated in the treatment of manic episodes of manic-depressive illness. maintenance therapy prevents or diminishes the intensity of subsequent episodes in those manic-depressive patients with a history of mania. typical symptoms of mania include pressure of speech, motor hyperactivity, reduced need for sleep, flight of ideas, grandiosity, elation, poor judgment, aggressiveness and possibly hostility. when given to a patient experiencing a manic episode, lithium carbonate extended-release tablets may produce a normalization of symptomatology within 1 to 3 weeks.

LITHIUM CARBONATE tablet, extended release Spojené štáty - angličtina - NLM (National Library of Medicine)

lithium carbonate tablet, extended release

a-s medication solutions - lithium carbonate (unii: 2bmd2gna4v) (lithium cation - unii:8h8z5uer66) - lithium carbonate extended-release tablets are indicated in the treatment of manic episodes of manic-depressive illness. maintenance therapy prevents or diminishes the intensity of subsequent episodes in those manic-depressive patients with a history of mania. typical symptoms of mania include pressure of speech, motor hyperactivity, reduced need for sleep, flight of ideas, grandiosity, elation, poor judgment, aggressiveness and possibly hostility. when given to a patient experiencing a manic episode, lithium carbonate extended-release tablets may produce a normalization of symptomatology within 1 to 3 weeks.

Tempo CALCIUM & VITAMINS KIDS Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

tempo calcium & vitamins kids

pba wholesale pty ltd - thiamine hydrochloride, quantity: 0.25 mg; riboflavin, quantity: 0.55 mg; nicotinamide, quantity: 6 mg; calcium pantothenate, quantity: 1.64 mg (equivalent: pantothenic acid, qty 1.5 mg); pyridoxine hydrochloride, quantity: 0.61 mg (equivalent: pyridoxine, qty 0.5 mg); folic acid, quantity: 50 microgram; cyanocobalamin, quantity: 0.75 microgram; ascorbic acid, quantity: 30 mg; d-alpha-tocopheryl acid succinate, quantity: 4.14 mg; biotin, quantity: 30 microgram; calcium carbonate, quantity: 49.93 mg (equivalent: calcium, qty 20 mg); potassium iodide, quantity: 98.19 microgram (equivalent: iodine, qty 75 microgram); magnesium amino acid chelate, quantity: 25 mg (equivalent: magnesium, qty 5 mg); zinc amino acid chelate, quantity: 7.5 mg (equivalent: zinc, qty 1.5 mg); manganese sulfate monohydrate, quantity: 154 microgram (equivalent: manganese, qty 50 microgram); colecalciferol, quantity: 0.0037 mg; betacarotene, quantity: 0.5 mg - tablet, chewable - excipient ingredients: hypromellose; maltodextrin; sorbitol; carmine; xylitol; lactose monohydrate; citric acid; silicon dioxide; microcrystalline cellulose; sucralose; magnesium stearate; calcium hydrogen phosphate dihydrate; carmellose sodium; maize starch; acacia; dl-alpha-tocopherol; sucrose; medium chain triglycerides; purified water; sodium alginate; pea starch; flavour - maintain/support healthy growth and development ; maintain/support general health and wellbeing ; maintain/support healthy immune system function ; maintain/support brain health

FlameX Suspension Malajzia - angličtina - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

flamex suspension

kck pharmaceutical industries sdn. bhd. - sodium alginate; calcium carbonate; dried aluminium hydroxide -

Impression material, dental, alginate Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

impression material, dental, alginate

dental brands australia - 35863 - impression material, dental, alginate - alginate for dental impressions

GAVISCON SACHETS ORAL POWDER COOLMINT FLAVOUR Milligram Oral Powder Írsko - angličtina - HPRA (Health Products Regulatory Authority)

gaviscon sachets oral powder coolmint flavour milligram oral powder

reckitt benckiser ireland ltd - sodium alginate sodium hydrogen carbonate calcium carbonate - oral powder - milligram